Analyzing the data, the year-on-year variations in percentage from 2024 to 2028 are as follows: 0.61%, 0.91%, 0.60%, and 0.59%. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is approximately 0.67%. This indicates a steady, but slow, growth in respiratory system medicine sales in Finland.
Future trends to watch for include advancements in medical technology, an increasing aging population leading to higher demand, and potential regulatory changes that could impact market dynamics. Close monitoring of global health issues such as pandemics could also affect demand and sales patterns significantly.